Skip to main content

Table 2 Clinical examination at discharge

From: An operational comparative study of quinine and artesunate for the treatment of severe malaria in hospitals and health centres in the Democratic Republic of Congo: the MATIAS study

  Quinine Artesunate
  2–59 months (N = 226) >5 years (N = 144) 2–59 months (N = 208) >5 years (N = 131)
Weight (kg) 11.1 (3.0) 32.8 (16.7) 11.2 (4.3) 27.2 (14.9)
Temperature (°C) 36.7 (0.5) 36.6 (0.5) 36.7 (0.4) 36.5 (0.4)
Pulse 100 (70–128) 90 (41–120) 90 (64–124) 85.4 (18.8)
Respiratory rate per minute 35 (22–40) 28 (16–48) 31.8 (6.6) 29.2 (8.0)
Persistence of signs at discharge 12 (5.4 %) 6 (4.3 %) 7 (3.4 %) 4 (3.0 %)
  1. Data are summarized as numbers (%), median (90 % central range) or mean (SD)
\